Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $54.4B |
| FY2017, ended Dec 31, 2017 | $94.2B |
| FY2018, ended Dec 31, 2018 | $73.1B |
| FY2019, ended Dec 31, 2019 | $81.2B |
| FY2020, ended Dec 31, 2020 | $99.3B |
| FY2021, ended Dec 31, 2021 | $111B |
| FY2022, ended Dec 31, 2022 | $124B |
| FY2023, ended Dec 31, 2023 | $148B |
| FY2024, ended Dec 31, 2024 | $173B |
| FY2025, ended Dec 31, 2025 | $267B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $490B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $38.5B |
| FY2017, ended Dec 31, 2017 | $45.5B |
| FY2018, ended Dec 31, 2018 | $54.7B |
| FY2019, ended Dec 31, 2019 | $53.8B |
| FY2020, ended Dec 31, 2020 | $41.7B |
| FY2021, ended Dec 31, 2021 | $51.0B |
| FY2022, ended Dec 31, 2022 | $59.4B |
| FY2023, ended Dec 31, 2023 | $67.1B |
| FY2024, ended Dec 31, 2024 | $64.8B |
| FY2025, ended Dec 31, 2025 | $67.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $74.7B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$67.0M | $4.53B |
| FY2017, ended Dec 31, 2017 | $754M | $4.81B |
| FY2018, ended Dec 31, 2018 | $6.15B | $5.28B |
| FY2019, ended Dec 31, 2019 | $6.09B | $5.86B |
| FY2020, ended Dec 31, 2020 | $3.00B | $5.35B |
| FY2021, ended Dec 31, 2021 | $6.49B | $6.11B |
| FY2022, ended Dec 31, 2022 | $6.71B | $6.47B |
| FY2023, ended Dec 31, 2023 | $10.3B | $11.3B |
| FY2024, ended Dec 31, 2024 | $10.8B | $10.0B |
| FY2025, ended Dec 31, 2025 | $8.88B | $8.92B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $10.8B | $10.7B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.20B |
| FY2017, ended Dec 31, 2017 | $8.32B |
| FY2018, ended Dec 31, 2018 | $7.89B |
| FY2019, ended Dec 31, 2019 | $8.29B |
| FY2020, ended Dec 31, 2020 | $9.35B |
| FY2021, ended Dec 31, 2021 | $9.25B |
| FY2022, ended Dec 31, 2022 | $7.00B |
| FY2023, ended Dec 31, 2023 | $6.98B |
| FY2024, ended Dec 31, 2024 | $6.89B |
| FY2025, ended Dec 31, 2025 | $9.98B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.71B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $30.1B |
| FY2017, ended Dec 31, 2017 | $28.7B |
| FY2018, ended Dec 31, 2018 | $30.7B |
| FY2019, ended Dec 31, 2019 | $31.4B |
| FY2020, ended Dec 31, 2020 | $28.0B |
| FY2021, ended Dec 31, 2021 | $31.4B |
| FY2022, ended Dec 31, 2022 | $31.7B |
| FY2023, ended Dec 31, 2023 | $29.1B |
| FY2024, ended Dec 31, 2024 | $31.7B |
| FY2025, ended Dec 31, 2025 | $36.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 21.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 586M |
| FY2017, ended Dec 31, 2017 | 598M |
| FY2018, ended Dec 31, 2018 | 576M |
| FY2019, ended Dec 31, 2019 | 550M |
| FY2020, ended Dec 31, 2020 | 545M |
| FY2021, ended Dec 31, 2021 | 536M |
| FY2022, ended Dec 31, 2022 | 516M |
| FY2023, ended Dec 31, 2023 | 499M |
| FY2024, ended Dec 31, 2024 | 478M |
| FY2025, ended Dec 31, 2025 | 465M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 460M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $218M |
| FY2017, ended Dec 31, 2017 | $0 | $206M |
| FY2018, ended Dec 31, 2018 | $3.80B | $197M |
| FY2019, ended Dec 31, 2019 | $4.05B | $205M |
| FY2020, ended Dec 31, 2020 | $1.13B | $202M |
| FY2021, ended Dec 31, 2021 | $2.67B | $200M |
| FY2022, ended Dec 31, 2022 | $4.23B | $193M |
| FY2023, ended Dec 31, 2023 | $4.97B | $208M |
| FY2024, ended Dec 31, 2024 | $7.70B | $223M |
| FY2025, ended Dec 31, 2025 | $5.19B | $242M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.22B | $257M |
Valuation
At current price- Market Cap
- $328B
- P/E
- 30.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.4×
- Price / Book
- 16.9×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $74.7B
- Revenue Growth YoY
- 18.4%
- Revenue CAGR 3Y
- 4.4%
- Revenue CAGR 5Y
- 10.1%
- EPS Growth YoY
- 18.2%
- Net Income Growth YoY
- 14.9%
Profitability
Trailing 12 months- Gross Margin
- 34.3%
- Operating Margin
- 17.5%
- Net Margin
- 14.5%
- FCF Margin
- 14.3%
- Return on Equity
- 57.0%
Earnings
Trailing 12 months- Net Income
- $10.8B
- EPS (diluted)
- $23.22
- EBITDA
- $15.5B
- Operating Income
- $13.1B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $6.71B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $103B
- Total Liabilities
- $83.2B
- Shareholders' Equity
- $19.4B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $13.6B
- Capital Expenditure
- $2.87B
- Free Cash Flow
- $10.7B
Dividends and risk
Last 12 months- Dividend Yield
- 0.9%
- Dividend / Share
- $6.28
- Beta (5Y)
- 1.58
Every ratio is calculated from the company’s reported figures.